112 related articles for article (PubMed ID: 3407193)
41. Serial serum calcitonin concentrations to evaluate response to therapy of patients with medullary thyroid carcinoma.
Athanassiades P; Piperingos G; Pandos P; Koutras D; Moulopoulos S
Chemioterapia; 1988 Jun; 7(3):195-7. PubMed ID: 3168076
[TBL] [Abstract][Full Text] [Related]
42. [Value of calcitonin determination in the evaluation of completeness of thyroidectomy in medullary carcinoma of the thyroid gland].
Wasylewski A; Skrzypek J; Kokot F; Sledziński Z
Endokrynol Pol; 1981; 32(3):239-44. PubMed ID: 7308165
[No Abstract] [Full Text] [Related]
43. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
Zink A; Blind E; Raue F
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
[TBL] [Abstract][Full Text] [Related]
44. Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.
Miyauchi A; Onishi T; Morimoto S; Takai S; Matsuzuka F; Kuma K; Maeda M; Kumahara Y
Ann Surg; 1984 Apr; 199(4):461-6. PubMed ID: 6712322
[TBL] [Abstract][Full Text] [Related]
45. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.
van Heerden JA; Grant CS; Gharib H; Hay ID; Ilstrup DM
Ann Surg; 1990 Oct; 212(4):395-400; discussion 400-1. PubMed ID: 2222011
[TBL] [Abstract][Full Text] [Related]
46. [Therapeutic strategy and prognosis of malignant struma].
Röher HD; Goretzki PE; Frilling A
Zentralbl Chir; 1990; 115(7):389-97. PubMed ID: 2195806
[TBL] [Abstract][Full Text] [Related]
47. [Endocrinological and clinicopathological studies on medullary thyroid carcinoma. Part 2: Biological behavior of the medullary thyroid carcinoma and its surgical implications (author's transl)].
Obara T
Nihon Gan Chiryo Gakkai Shi; 1977 Mar; 12(1):12-23. PubMed ID: 559026
[No Abstract] [Full Text] [Related]
48. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
Palmer BV; Harmer CL; Shaw HJ
Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
[TBL] [Abstract][Full Text] [Related]
49. Management of medullary carcinoma of the thyroid.
Simpson WJ; Palmer JA; Rosen IB; Mustard RA
Am J Surg; 1982 Oct; 144(4):420-2. PubMed ID: 7125073
[TBL] [Abstract][Full Text] [Related]
50. Nonfamilial medullary thyroid carcinoma.
Rossi RL; Cady B; Meissner WA; Wool MS; Sedgwick CE; Werber J
Am J Surg; 1980 Apr; 139(4):554-60. PubMed ID: 7369463
[No Abstract] [Full Text] [Related]
51. Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma.
Modigliani E; Cohen R; Joannidis S; Siame-Mourot C; Guliana JM; Charpentier G; Cassuto D; Bentata Pessayre M; Tabarin A; Roger P
Clin Endocrinol (Oxf); 1992 Feb; 36(2):183-6. PubMed ID: 1568350
[TBL] [Abstract][Full Text] [Related]
52. CT scanning as an adjunct to screening for medullary carcinoma of the thyroid.
Heron CW; Ponder BA; Hunter-Craig ID
Clin Radiol; 1990 Mar; 41(3):209-10. PubMed ID: 1969787
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels.
Miyauchi A; Matsuzuka F; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
World J Surg; 1988 Oct; 12(5):610-5. PubMed ID: 3245215
[No Abstract] [Full Text] [Related]
54. Radioimmunoassay of human plasma calcitonin.
Frölich M; Kassenaar AA; Smeenk D
Horm Metab Res; 1971 Jul; 3(4):297-8. PubMed ID: 5167036
[No Abstract] [Full Text] [Related]
55. Plasma human calcitonin (hCT) levels in normal and pathologic conditions, and their responses to short calcium or tetragastrin infusion.
Adachi I; Abe K; Tanaka M; Yamaguchi K; Miyakawa S
Endocrinol Jpn; 1976 Dec; 23(6):517-26. PubMed ID: 191250
[TBL] [Abstract][Full Text] [Related]
56. Thyroidectomy for non-familial medullary carcinoma.
Roediger WE
Br J Surg; 1976 May; 63(5):343-5. PubMed ID: 1268473
[TBL] [Abstract][Full Text] [Related]
57. Prostaglandins: role in the humoral manifestations of medullary carcinoma of the thyroid and inhibition by somatostatin.
Roberts LJ; Hubbard WC; Bloomgarden ZT; Bertagna XY; McKenna TJ; Rabinowitz D; Oates JA
Trans Assoc Am Physicians; 1979; 92():286-91. PubMed ID: 44926
[No Abstract] [Full Text] [Related]
58. [Thyroid cancer, its diagnosis and surgical treatment].
Abdeluakhab M; Mziuad O; Gavrailov M
Khirurgiia (Sofiia); 1995; 48(2):39-43. PubMed ID: 8531446
[No Abstract] [Full Text] [Related]
59. Surgical implications of medullary carcinoma of the thyroid.
Watson AJ; Johnston ID
Proc R Soc Med; 1970 Jun; 63(6):612-5. PubMed ID: 5453460
[No Abstract] [Full Text] [Related]
60. Calcitonin in human serum. Detection by tissue culture bioassay in medullary carcinoma of the thyroid and other disorders.
Raisz LG; Au WY; Simmons H; Mandelstam P
Arch Intern Med; 1972 Jun; 129(6):889-93. PubMed ID: 5033285
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
